ACCELERON PHARMA INC SEC Filings

Filed On	Filing
02 Dec 2021	15-12B
24 Nov 2021	ACCELERON PHARMA INC.
22 Nov 2021	8-K: Completion of Acquisition or Disposition of Assets; Notice of Delisting or Failure to Satisfy a Listing Rule +4 more
22 Nov 2021	Form 4: Zakrzewski Joseph S, Director Disposed of 34,499 shares (Tender Offer) · Disposed of 53,907 Option to Purchase Common Stock (Disposition to Issuer)
22 Nov 2021	Form 4: Malik Kemal, Director Disposed of 1,622 shares (Tender Offer) · Disposed of 21,178 Option to Purchase Common Stock (Disposition to Issuer)
22 Nov 2021	Form 4: Hite Christopher, Director Disposed of 930 shares (Tender Offer) · Disposed of 12,115 Option to Purchase Common Stock (Disposition to Issuer)
22 Nov 2021	Form 4: Smith Karen L., Director Disposed of 1,622 shares (Tender Offer) · Disposed of 22,932 Option to Purchase Common Stock (Disposition to Issuer)
22 Nov 2021	Form 4: Mccourt Thomas A, Director Disposed of 6,044 shares (Tender Offer) · Disposed of 18,907 Option to Purchase Common Stock (Disposition to Issuer)
22 Nov 2021	Form 4: Kearney Terrence C, Director Disposed of 6,749 shares (Tender Offer) · Disposed of 31,072 Option to Purchase Common Stock (Disposition to Issuer)
22 Nov 2021	Form 4: Hamill Laura, Director Disposed of 474 shares (Tender Offer) · Disposed of 10,280 Option to Purchase Common Stock (Disposition to Issuer)
22 Nov 2021	Form 4: Nader Francois, Director Disposed of 6,749 shares (Tender Offer) · Disposed of 74,483 Option to Purchase Common Stock (Disposition to Issuer)
22 Nov 2021	Form 4: Veness Adam M, SVP, General Counsel and Sec. Disposed of 23,423 shares (Tender Offer) · Disposed of 65,990 Option to Purchase Common Stock (Disposition to Issuer)
22 Nov 2021	Form 4: Kango Sujay, EVP, Chief Commercial Officer Disposed of 18,509 shares (Tender Offer) · Disposed of 95,730 Option to Purchase Common Stock (Disposition to Issuer)
22 Nov 2021	Form 4: Backstrom Jay T., EVP, Research and Development Disposed of 21,233 shares (Tender Offer) · Disposed of 117,859 Option to Purchase Common Stock (Disposition to Issuer)
22 Nov 2021	Form 4: Mclaughlin Kevin F, SVP, CFO and Treasurer Disposed of 10,681 shares (Tender Offer) · Disposed of 77,565 Option to Purchase Common Stock (Disposition to Issuer)
22 Nov 2021	Form 4: Dable Habib J, Director Disposed of 98,450 shares (Tender Offer) · Disposed of 614,281 Option to Purchase Common Stock (Disposition to Issuer)
22 Nov 2021	25-NSE
22 Nov 2021	SC 14D9/A
22 Nov 2021	SC TO-T/A
17 Nov 2021	ACCELERON PHARMA INC.

Comments